Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Leading pharmaceutical companies in Norway 2019, by turnover

Unlike its Scandinavian neighbors, the key players in the Norwegian pharmaceutical market are not domestic companies, but rather branches of major international giants in the sector. As of 2019 the leading pharmaceutical company in Norway, in terms of turnover, was Novartis Norge AS. The company generated a turnover of over 1.5 billion Norwegian kroner, and had a market share of 5.9 percent. Soon after followed Pfizer AS, with a market share of 4.8 percent, and MSD Norge, with a market share of 4.7 percent.

Pharmaceutical sales

   The value of pharmaceutical sales in Norway in 2018 was around 28.8 billion Norwegian kroner. The largest part of the pharmaceutical sales came from prescription pharmaceuticals. In particular, the group of pharmaceuticals that generated the largest turnover in 2018 was drugs for obstructive airway diseases, which had a turnover of around 1.2 billion Norwegian kroner.

Nonprescription pharmaceuticals

  The total turnover generated from nonprescription pharmaceuticals in Norway reached a value of around 1.6 billion Norwegian kroner, after several years of increasing turnover. That year, the leading nonprescription pharmaceutical company in Norway, by market share, was GSK Consumer Health, with a market share of 23.4 percent. It was followed by Karo Pharma AS, with a market share of 17.1 percent.

Leading pharmaceutical companies in Norway in 2019, by turnover

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

April 2020

Region

Norway

Survey time period

2019

Special properties

top 15

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Norway "

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.